The United States federal appeals court has ruled that the Food and Drug Administration (FDA) must reconsider its decision to deny six companies permission to sell e-cigarette products. The ruling has caused a conflict between the court and Washington, D.C. The FDA has declined to comment on the decision.
Attorney Jerad Najvar of the Najvar law firm, representing e-cigarette liquid manufacturers Diamond Vapor, Union Street Brands, Vapor Unlimited LLC, and Johnny Copper LLC, stated that the FDA's belief that it can simply dismiss marketing plan review reports is incorrect. He explained that the agency mistakenly believes that his clients' liquid products have the same youth appeal as pre-filled liquid cartridges. The lawyer for Pop Vapor Co, the remaining company, did not immediately respond.
Electronic cigarettes deliver nicotine through the vaporization of liquid rather than the combustion of tobacco. In 2016, the US Food and Drug Administration determined that electronic cigarettes are subject to their regulation, just like traditional tobacco products, and allowed manufacturers to apply for approval before 2020.
Last autumn, these six companies petitioned with the 11th Circuit Court to review the FDA's denial of their applications to market various flavored e-cigarettes and liquids. These were among the over 55,000 such products that the agency rejected last year.
Chief Justice William Pryor and Circuit Judge Andrew Brasher jointly stated that the FDA's reasoning was due to "a federal district court judge refusing to hear arguments from the defendant regarding their reform plans or their impact on their family, because the judge, based on their experience, found these things to be irrelevant.
Circuit judge Robin Rosenbaum, who holds a dissenting opinion, stated that sending the case back to the US Food and Drug Administration would be "futile".
Statement:
This article is compiled from third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS is also unable to confirm the authenticity and accuracy of the article's content. The compilation of this article is intended for industry exchange and research purposes only.
Due to limitations in the level of translation, the compiled article may not accurately convey the original meaning. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, and foreign-related statements and positions.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
